IP Library Granted Patent US 8,841,606
Granted Patent B2
US 8,841,606 · App. 13/253,312 · Granted Sep 23, 2014

Mass spectrometry

Inventors: Jose M. Castro-Perez (New Providence, NJ); Alan Millar (Southborough, MA); Robert S. Plumb (Milford, MA)
Assignee: Micromass UK Limited
H01J49/0031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,841,606
App. No.
13/253,312
Granted
Sep 23, 2014
Kind
B2
Abstract

A method of searching for potentially unknown metabolites of pharmaceutical compounds is disclosed. The accurate mass of a pharmaceutical compound will generally be known and can be rendered in the form of an integer nominal mass or mass to charge ratio component and a decimal mass or mass to charge ratio component. Possible metabolites are searched for on the basis of having a decimal mass or mass to charge ratio component which is substantially very similar to the decimal mass or mass to charge ratio of the parent pharmaceutical compound.

Claims (32)

1. A method of mass spectrometry comprising:

analysing ions with a mass analyser;

searching mass data or a mass spectrum for ions having a decimal mass or mass to charge ratio component that falls within a decimal mass or mass to charge ratio window;

selecting ions of potential interest for further analysis by virtue of the fact that the decimal mass or mass to charge ratio components of the ions falls within the decimal mass or mass to charge ratio window, wherein a profile of the decimal mass or mass to charge ratio window varies as a function of ΔM, wherein ΔM is the difference in the accurate mass or mass to charge ratio between that of a first substance or ion and a second substance or ion; and

providing an output based at least in part on said searching.

2. The method of claim 1 , wherein selecting the ions of potential interest for further analysis comprises fragmenting the ions of potential interest.

3. The method of claim 2 , further comprising mass analyzing the resulting fragment product ions to obtain a mass spectrum of the fragment product ions.

4. The method of claim 1 , wherein the first substance or ion comprises or relates to a pharmaceutical compound, drug or active component.

5. The method of claim 1 , wherein the second substance or ion comprises or relates to a metabolite or derivative of the first substance or ion.

6. The method of claim 1 , wherein selecting ions of potential interest comprises filtering out, attenuating, removing, or reducing the significance of ions having a decimal mass or mass to charge ratio component which falls outside of the decimal mass or mass to charge ratio window.

7. The method of claim 1 , wherein the profile of the decimal mass or mass to charge ratio window varies as a function of ΔM in a symmetrical or asymmetrical manner.

8. A method of mass spectrometry comprising:

analysing ions with a mass analyser;

searching mass data or a mass spectrum for ions having a decimal mass or mass to charge ratio component that falls within a decimal mass or mass to charge ratio window;

filtering out, removing, attenuating, or reducing the significance of ions having a decimal mass or mass to charge ratio component which falls outside of the decimal mass or mass to charge ratio window; wherein a profile of the decimal mass or mass to charge ration window varies as a function of ΔM, wherein ΔM is the difference in the accurate mass or mass to charge ratio between that of a first substance or ion and a second substance or ion; and

providing an output based at least in part on said searching.

9. The method of claim 8 , further comprising fragmenting ions having a decimal mass or mass to charge ratio component falling within the decimal mass or mass to charge ratio window.

10. The method of claim 9 , further comprising mass analyzing the resulting fragment product ions to obtain a mass spectrum of the fragment product ions.

11. The method of claim 8 , wherein the first substance or ion comprises or relates to a pharmaceutical compound, drug or active component.

12. The method of claim 8 , wherein the second substance or ion comprises or relates to a metabolite or derivative of the first substance or ion.

13. The method of claim 1 , wherein the profile of the decimal mass or mass to charge ratio window varies as a function of ΔM in a symmetrical or asymmetrical manner.

14. A method of mass spectrometry comprising:

analysing ions with a mass analyser;

obtaining a parent ion mass spectrum of a sample containing one or more metabolites of interest;

searching for ions of potential interest by searching the parent ion mass spectrum for mass peaks which meet the criteria that a decimal mass or mass to charge ratio component of a corresponding ion is within a decimal mass or mass to charge ratio window about a decimal mass or mass to charge ratio component of the parent ion;

selecting ions of potential interest for further analysis by virtue of the fact that the respective decimal mass or mass to charge ratio components of the ions falls within the decimal mass or mass to charge ratio window, wherein a size of the decimal mass or mass to charge ratio window varies as a function of a difference in the accurate mass or mass to charge ratio between that of the parent ion and ions being searched for; and

providing an output based at least in part on said searching.

15. The method of claim 14 , wherein selecting the ions of potentials interest for further analysis comprises fragmenting the ions of potential interest.

16. The method of claim 15 , further comprising mass analyzing the resulting fragment product ions to obtain a mass spectrum of the fragment product ions.

17. The method of claim 14 , wherein selecting ions of potential interest comprises filtering out, attenuating, removing, or reducing the significance of ions having a decimal part of an accurate mass or mass to charge ratio which falls outside of the decimal mass or mass to charge ratio window.

18. The method of claim 14 , wherein the ions of potential interest comprise one or more metabolites of the parent ion.

19. The method of claim 14 , wherein the profile of the decimal mass or mass to charge ratio window varies in a symmetrical or asymmetrical manner.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2014
From: CASTRO-PEREZ, JOSE M.; MILLAR, ALAN; PLUMB, ROBERT S.
To: MICROMASS UK LIMITED
Reel/Frame 033569/0228 →
Priority Claims (1)
GB 0415046.2 · Jul 5, 2004 · national
Continuity (3)
Continuation 11571338
Provisional Application 60584139 · Jul 1, 2004
Related Publication 20120112055A1 · May 10, 2012